Clinical and epidemiological aspects of the dengue epidemic in Recife, PE, 2002

被引:24
作者
Montenegro, D
Lacerda, HR
Lira, TM
de Oliveira, DSC
de Lima, AAF
Guimaraes, MJB
de Vasconcelos, PG
机构
[1] Secretaria Municipal Saude, Diretoria Vigilancia Epidemiol, Recife, PE, Brazil
[2] Hosp Correia Picanco Sistema Unico Saude, Recife, PE, Brazil
[3] Univ Fed Pernambuco, Curso Posgrad Med Trop, Recife, PE, Brazil
[4] Univ Fed Pernambuco, Dept Clin Med, Recife, PE, Brazil
[5] Univ Pernambuco, Dept Clin Med, Recife, PE, Brazil
关键词
dengue; hemorrhagic fever of dengue; necropsia; death;
D O I
10.1590/S0037-86822006000100002
中图分类号
R38 [医学寄生虫学]; Q [生物科学];
学科分类号
07 ; 0710 ; 09 ; 100103 ;
摘要
This paper shows data regarding dengue and hemorrhagic fever of the dengue epidemic in Recife in 2002 and the clinical, laboratorial and necropsy results from the 14 patients who died that year. The sorotype Den-3 was detected in 76.3% of cases. The majority of deaths occurred among men, over 20 years old, on the 116 day of disease, attended in the private hospitals. The average values of the hematocryt and platelets were 40.7% and 56,313p/mm(3), respectively. Hepatitis, with high levels of transaminases, occurred in the majority of patients, who generally were anicteric. Of the fourteen deaths, 13 received laboratorial confirmation of the infection. In eight cases death occurred due to hemorrhagic phenomena, however, in the other 6 cases significant bleeding was not identified. Vascular collapse (chock) was present in 12 (85.7%) cases, with or without the association of major bleeding, and was the most important cause of death.
引用
收藏
页码:9 / 13
页数:5
相关论文
共 23 条
[1]   Vascular leak syndrome: a side effect of immunotherapy [J].
Baluna, R ;
Vitetta, ES .
IMMUNOPHARMACOLOGY, 1997, 37 (2-3) :117-132
[2]  
DENGUE NS, 1999, J PEDIATR, V75, P9
[3]   Dengue and dengue hemorrhagic fever [J].
Gubler, DJ .
CLINICAL MICROBIOLOGY REVIEWS, 1998, 11 (03) :480-+
[4]  
Guzman Maria G., 2002, International Journal of Infectious Diseases, V6, P118, DOI 10.1016/S1201-9712(02)90072-X
[5]   Dengue and dengue hemorrhagic fever in the Americas: lessons and challenges [J].
Guzman, MG ;
Kouri, G .
JOURNAL OF CLINICAL VIROLOGY, 2003, 27 (01) :1-13
[6]  
Hongsiriwon Suchat, 2002, Southeast Asian Journal of Tropical Medicine and Public Health, V33, P49
[7]   Early clinical and laboratory indicators of acute dengue illness [J].
Kalayanarooj, S ;
Vaughn, DW ;
Nimmannitya, S ;
Green, S ;
Suntayakorn, S ;
Kunentrasai, N ;
Viramitrachai, W ;
Ratanachueke, S ;
Kiatpolpoj, S ;
Innis, BL ;
Rothman, L ;
Nisalak, A ;
Ennis, FA .
JOURNAL OF INFECTIOUS DISEASES, 1997, 176 (02) :313-321
[8]   Immunopathogenesis of dengue virus infection [J].
Lei, HY ;
Yeh, TM ;
Liu, HS ;
Lin, YS ;
Chen, SH ;
Liu, CC .
JOURNAL OF BIOMEDICAL SCIENCE, 2001, 8 (05) :377-388
[9]   Risk factors for hemorrhage in severe dengue infections [J].
Lum, LCSL ;
Goh, AYT ;
Chan, PWK ;
El-Amin, ALM ;
Lam, SK .
JOURNAL OF PEDIATRICS, 2002, 140 (05) :629-631
[10]  
LYRA MT, 2002, MOSTRA NACL EXPERIEN